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Recent reports of the oral administration of
griseofulvin in various fungus infections have
opened up a new approach to the treatment of
these diseases. Williams, Marten and Sarkany (1)
observed good initial results in ten patients. Blank
and Roth (2) obtained a favorable response in
31 patients, except for infections caused by Can-
dida albicans, Malessezia furfur and Blastomyces
dermetitidis. They found that fungus lesions on
the glabrous skin healed in two weeks, those on the
feet in four weeks, and nail infections after three
months. These were only preliminary results in
small numbers of patients, but should they be
substantiated in larger series, should few relapses
occur after sufficiently long follow-up periods,
and especially if the fungi do not become resistant
to this new antibiotic, then a great step forward in
dermatology will have been made.
With regard to tinea capitis, one case (of 60
years duration) due to T. tonsurans, one due to
M. canis (2) and three caused by M. audouini
(1, 2) are known to have been treated and healed
by griseofulvin. No reports seem so far to have
been made of the effect on the especially stubborn
hair infection caused by Trichophyton violaceum,
which is widespread in Eastern Europe, in the
Mediterranean area and in large parts of Asia.
Such infection accounts for almost 90 per cent of
all cases of tinea capitis seen in this country (3),
and large numbers of children are infected during
epidemics. Tinea capitis caused by T. violeceum
has so far not yielded to simple external treatment
and does not necessarily heal after puberty. Cure
necessitates X-ray irradiation followed by me-
chanical epilation of the entire scalp and applica-
tions of iodine to the bald skin. The latent dangers
of using ionizing irradiation for an essentially
minor disease, the marked discomfort to the child
during the mechanical epilation and the deep
psychological disturbance which may result from
the prolonged period of baldness all justify a
search for a better treatment. It is therefore of
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special interest to determine whether these cbil-
dren can now be cured without resorting to X-ray
therapy.
CLINICAL REPORT
Two female children, aged 5 and 7 years respec-
tively, suffering from tinea eapitis, were hospital-
ized for controlled griseofulvin therapy. On the
scalp of each child were several bald-looking,
scaly patches. In the scales or fnllicular orifices
there were broken-off hair stumps, which micro-
scopically were seen to be filled with spores. Cul-
tures yielded T. eiolaceum.
The childrens' general condition was good and
no abnormalities were detected on routine physi-
cal examination. During therapy the stools, urine,
blood picture and blood chemistry were repeatedly
examined.
The older child was given 0.5 gm. griseofulvin for
2 days, then 1.0 gm. daily for 70 days, and 0.5 gm.
for a further 28 days. The yuunger child received
0.5 gm daily for the first 2 days, 0.75 gm. daily for
62 days, and 0.25 gm. daily for another 28 days.
Their scalps were inspected daily and hair from
the affected areas examined microscopically two
or three times a week. Cultures were also usually
made on these occasions.
Hairs from the older child became microscopi-
cally negative on the 54th day of treatment. At
this time only a few hair stumps were found at the
sites of former infection and on microscopic
examination these were seen to be disintegrating
hairs, free from fungal elements. On the 61st and
64th days fungal elements were detected in a few
hairs around the healing site of a biopsy which
had been performed 13 days earlier. However the
microscopic picture was different from the usual
in that the hair itself was invaded by only a few
hyphae whereas the horny layer around contained
very thick segmented hyphal fragments. On the
72nd day the microscopic examination once again
revealed no signs of infection, and remained nega-
tive during a further observation period of one
month. Treatment was stopped on the 98th day.
'fhe younger child showed marked clinical im-
provement 46 days after the start of treatment.
Fewer broken hairs were seen and new normal
appearing hairs were growing at the sites of infec-
tion. The patches however were still scaly, and
between and on top of the scales were many free-
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lying broken hair stumps which had apparently
been actively expelled from the hair follicles.
Hairs plucked from the follicular orifices became
microscopically negative for fungi on the 54th day
of treatment, By the 56th day the scalp showed no
clinical evidence of tinea and only a diffuse scali-
ness was present. A few groups of spores were
found in a scale on the 80th day but there was no
evidence of fungus infection in the hairs. There
were similar findings on the 83rd, 90th and 97th
days. The scales could be almost completely re-
moved by thorough shampooing, and after the
101st day microscopic examinations remained
negative.
COMMENT
Griscofulvin is a chlorine-containing metabolic
product of several penicillium species. It first
aroused interest because of its effect on certain
fungal diseases of plants and for some time was
not considered as a potential systemic fungicidal
agent in animals because its very low oral toxicity
raised doubts as to it's absorption (4). Its activity
on various phytopathogcnic fungi has been de-
scribed by Brian (5, 6). Gentles (7) found that it
controlled experimental microsporum and tricho-
phyton infections in guinea pigs, and it has been
used with good results by Lauder and O'Sullivan
(8) in cattle infected by T. verrucosuni.
Griseofulvin has been shown to have an anti-
mitotic effect in animals when given in very large
doses by the intraperitoneal or intravenous route.
Regular laboratory examinations were performed
in our patients during their hospitalization period
of three months. Apart from occasional traces of
albumin in the urine and a slight rise in the lym-
phocyte count there were no pathological findings.
Their general health remained excellent.
SUMMARY
Two children with tinca capitis due to T. viola-
ceum were treated by oral griscofulvin under
strict control as hospital in-patients.
Clinical and microscopic cure was achieved after
92—100 days of treatment.
The antibiotic did not cause any serious toxic
reactions in the dosage employed.
An active shedding of infected hairs was noticed
during the early stages of treatment.
Additional Notes: Since this paper was written,
two further cases of tinca capitis due to T vio-
laceum have been treated with and cured by
griseofulvin, on an ambulatory basis. They were a
mother, age 30 years, and her child, age 1 year
3 months. They received 1 gm. and 0.25 gm.
griseofulvin daily respectively. Examinations for
fungus revealed no organisms after 29 days.
Treatment was continued for a total of 49 days,
and there were no signs of the disease 3 months
later.
Noted since publication is the following refer-
ence:
SULZBRRaRR, M. B. AND BARR, R. L.: Griseoful-
Yin. An oral antibiotic for the treatment of
many common fungus infections of the skin,
hair and nails. Exccrpta Medica, Section 13,
Vol. 13: 145, March 1959.
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